Markus Wartmann

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Novartis (Switzerland)18%
• Harvard University9.8%
• Dana-Farber Cancer Institute8.2%
• Inserm8%
• Novartis Institutes for BioMedical Research7.7%
• The University of Texas MD Anderson Cancer Center6.3%
• Other42%

Fields

• Biochemistry, Genetics and Molecular Biology50.1%
• Medicine37.4%
• Chemistry3.4%
• Immunology and Microbiology2.6%
• Neuroscience2.4%
• Computer Science1.6%
• Other2.6%

Topics

• Protein Kinase Regulation and GTPase Signaling17.1%
• Melanoma and MAPK Pathways10.4%
• Cancer-related Molecular Pathways8.8%
• PI3K/AKT/mTOR signaling in cancer8.2%
• Fibroblast Growth Factor Research7.8%
• Advanced Breast Cancer Therapies7.1%
• Other40.7%